formulaite
Our teams
Fewer experiments. Deeper insights. Better RNA delivery.
Formulaite is developing ALINA (Active Learning Inference for Nucleic Acids), an AI-powered platform for predicting and optimizing RNA nanocarriers. By combining machine learning, molecular dynamics simulations, and experimental validation, ALINA accelerates the development of RNA therapeutics. The goal is to reduce development times, costs, and the need for animal testing, as well as to make the development of effective RNA formulations more predictable and efficient.
Vision of formulaite:
"Being accepted into MAxL is an important milestone for formulaite. Access to state-of-the-art laboratory infrastructure, a strong network, and Munich’s dynamic biotechnology ecosystem creates the ideal conditions for us to further develop our technology and validate it in collaboration with industry partners."
The team of formulaite:
- Dr. Joschka Müller, LMU München, Approbierter Apotheker, Promotion in Pharmazeutischer Technologie und Biopharmazie, Fokus auf Nanoparticle Formulation und Strategie - LinkedIn profile
- Dr. Felix Sieber-Schäfer, LMU München, Approbierter Apotheker, Promotion in Pharmazeutischer Technologie und Biopharmazie, Fokus auf Machine Learning und Molecular Dynamics - LinkedIn profile
- Dr. Min Jiang, LMU München, Studium der Pharmazie, Promotion in Pharmazeutischer Technologie und Biopharmazie, Fokus auf in vitro und in vivo Implementation - LinkedIn profile
- Florian Orbach, TU München, Studium Management und Technology an der TU München, Fokus auf Business Development - LinkedIn profile
- Prof. Dr. Olivia Merkel, LMU München, Approbierte Apothekerin, Lehrstuhlinhaberin für Drug Delivery an der LMU München, Scientific Advisor - LinkedIn profile